Evidence map›Paper›PMID 41402658›Full record

ArticleInflammation2025

NOX2-Dependent Phagocyte Signaling Mediates Silica-Induced Murine Lung Injury via Macrophage-Neutrophil Interactions.

Masahiro Kusaka, Koji Sakamoto, Yoshiki Ikeyama, Yuki Kondo, Tomoya Hayashi, Akira Ando, Yuta Mori, Tomonori Sato, Miyoko Matsushima, Atsushi Suzuki and 7 more

Abstract read
In one paragraph

Article in Inflammation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Masahiro Kusaka *Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan.
Koji Sakamoto *Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan. sakakoji@med.nagoya-u.ac.jp.
Yoshiki IkeyamaDepartment of Respiratory Medicine, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan.
Yuki KondoDepartment of Respiratory Medicine, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan.
Tomoya HayashiDivision of Vaccine Science, Department of Microbiology and Immunology, The Institute of Medical Science (IMSUT), The University of Tokyo, Tokyo, 108-8639, Japan.
Akira AndoDepartment of Respiratory Medicine, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan.
Yuta MoriDepartment of Respiratory Medicine, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan.
Tomonori SatoDepartment of Respiratory Medicine, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan.
Miyoko MatsushimaDepartment of Integrated Health Sciences, Nagoya University Graduate School of Medicine, Nagoya, 466-8550, Japan.
Atsushi SuzukiDepartment of Respiratory Medicine, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan.
Saeka FujitaDepartment of Respiratory Medicine, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan.
Yukihiro ShirakiDepartment of Pathology, Nagoya University Graduate School of Medicine, Nagoya, 466-8550, Japan.
Tsutomu KawabeDepartment of Integrated Health Sciences, Nagoya University Graduate School of Medicine, Nagoya, 466-8550, Japan.
Atsushi EnomotoDepartment of Pathology, Nagoya University Graduate School of Medicine, Nagoya, 466-8550, Japan.
Ken J IshiiDivision of Vaccine Science, Department of Microbiology and Immunology, The Institute of Medical Science (IMSUT), The University of Tokyo, Tokyo, 108-8639, Japan.
Naozumi HashimotoDepartment of Respiratory Medicine, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan.
Makoto IshiiDepartment of Respiratory Medicine, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan.

Funding

Japan Agency for Medical Research and Development 24gm4010025h0001Japan Agency for Medical Research and Development 24gm4010025h0002Japan Agency for Medical Research and Development 24gm4010025h0003Japan Science and Technology Agency JPMJCR17H3Japan Society for the Promotion of Science 20K21599
6 · The paper itself

Abstract

In phagocytes, reactive oxygen species produced by NADPH oxidase 2 (NOX2) play a crucial role in the digestion of phagocytosed material as well as in immune response signaling. We recently reported the role of NOX2 in regulating inflammatory signaling in macrophages following silica nanoparticles (SiNPs) phagocytosis in vitro. However, it remains unclear whether pharmacological inhibition of NOX2 signaling modulates the SiNPs-induced lung injury. Here, we show that local administration of a NOX2-specific inhibitory peptide effectively suppressed neutrophilic lung injury caused by airway exposure to SiNPs. Formation of neutrophil extracellular traps (NETs) by neutrophils recruited to the alveoli was evident in SiNPs-induced lung injury tissues, as assessed by histological evidence of activated neutrophil elastase and myeloperoxidase as well as an increased DNA-histone concentration in bronchoalveolar lavage. Intratracheal administration of gp91ds-tat, a synthetic inhibitory peptide with specific activity against NOX2, significantly reduced the production of neutrophil chemoattractants in SiNPs-induced lung injury. Furthermore, NOX2 inhibition also suppressed NET formation upon silica-induced lung injury in vivo. We also confirmed that an NOX2 inhibitory peptide prevented NETs formation in neutrophils stimulated with silica nanoparticles in vitro. We also observed a potential role of silica-induced NETs in macrophage priming in vitro. Collectively, our findings suggest that silica-induced lung injury is exacerbated through a positive feedback loop, in which macrophages and neutrophils amplify inflammation via the production of chemoattractants and formation of NETs, respectively. The airway administration of NOX2 inhibitors effectively disrupts this feedback loop formed by two types of phagocytes, thereby mitigating silica-induced lung injury.

Indexed as

Lung InjuryMacrophagesNADPH Oxidase 2NeutrophilsPhagocytesSilicon DioxideAnimalsExtracellular TrapsMaleMiceMice, Inbred C57BLNanoparticlesPhagocytosisSignal TransductionCybb protein, mouseNADPH Oxidase 2Silicon DioxideAcute lung injuryNADPH oxidase 2Neutrophil extracellular trapsSilica nanoparticles

Identifiers

PMID41402658
PMCPMC12708739

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.